Cureus. 2016 May 27;8(5):e624. doi: 10.7759/cureus.624.
Socioeconomic Factors Impact Inpatient Mortality in Pediatric Lymphoma Patients.
Cureus
Yana Puckett, Anh Ta
Affiliations
Affiliations
- Surgery, Texas Tech University Health Sciences Center.
- School of Medicine, Saint Louis University.
PMID: 27433403
PMCID: PMC4934790 DOI: 10.7759/cureus.624
Abstract
PURPOSE: Our objective was to determine the risk factors for inpatient mortality of pediatric patients diagnosed with lymphoma through the utilization of a large national pediatric database.
METHODS: This cross-sectional study uses data from the Healthcare Cost and Utilization Project Kids' Inpatient Database (HCUP KID) for the year of 2012 to estimate the risk factors for inpatient mortality for pediatric patients diagnosed with lymphoma. All patients diagnosed with lymphoma between the ages of one and 18 years were included. Chi-square test was used to analyze categorical variables. Independent t-test was used to analyze continuous variables.
RESULTS: A total of 2,908 study subjects with lymphoma were analyzed. Of those, 56.1% were male and the average age was three years old. Total inpatient mortality was 1.2% or 34 patients. We found that patients with four or more chronic conditions were much more likely to die while hospitalized (p < 0.0001). In addition, we also saw that patients with median household incomes below $47,999 dollars (p = 0.05) having a need for a major procedure (p = 0.008) were associated with inpatient mortality. Congestive heart failure, renal failure, coagulopathy, metastatic disease, and electrolyte abnormalities were all found to be associated with inpatient mortality.
CONCLUSIONS: Pediatric lymphoma mortality in children is not only influenced by their medical condition but also by their socioeconomic condition as well.
Keywords: chronic illness; lymphoma; pediatric cancer; pediatric malignancies; socioeconomic status
References
- J Public Health (Oxf). 2010 Jun;32(2):236-44 - PubMed
- Leukemia. 2009 Feb;23(2):323-31 - PubMed
- Asian Pac J Cancer Prev. 2010;11(6):1755-9 - PubMed
- Int J Radiat Oncol Biol Phys. 2001 Dec 1;51(5):1209-18 - PubMed
- Nephron Clin Pract. 2005;100(3):c86-91 - PubMed
- Cancer. 1993 Sep 15;72(6):2049-57 - PubMed
- Infect Control Hosp Epidemiol. 2010 Oct;31(10):1049-56 - PubMed
- J Pediatr Hematol Oncol. 2014 Oct;36(7):e403-9 - PubMed
- Pediatr Hematol Oncol. 2006 Jan-Feb;23(1):65-70 - PubMed
- Int J Cancer. 2016 Jun 15;138(12):2856-66 - PubMed
- Blood. 2007 Apr 1;109(7):2736-43 - PubMed
- Blood. 2013 Apr 18;121(16):3153-60 - PubMed
- CA Cancer J Clin. 2014 Mar-Apr;64(2):83-103 - PubMed
- J Clin Oncol. 2003 May 15;21(10):2026-33 - PubMed
- Epidemiol Rev. 2002;24(2):269-79 - PubMed
- Arch Dis Child. 1992 Nov;67(11):1378-83 - PubMed
- Eur J Pediatr. 2004 Jun;163(6):313-9 - PubMed
- PLoS One. 2014 Feb 26;9(2):e89482 - PubMed
- J Clin Oncol. 2007 Sep 1;25(25):3915-22 - PubMed
- Blood. 2014 Jun 5;123(23):3553-62 - PubMed
- Cancer Treat Rev. 2010 Jun;36(4):277-85 - PubMed
- J Clin Oncol. 2000 Apr;18(7):1500-7 - PubMed
- Intensive Care Med. 2014 Oct;40(10):1536-44 - PubMed
- J Pediatr Hematol Oncol. 2012 Oct;34(7):e266-70 - PubMed
- Clin Epidemiol. 2013 Nov 01;5(Suppl 1):3-29 - PubMed
Publication Types